港股異動 | 泡泡瑪特(9992.HK)連續3日反彈 回購+機構唱好
格隆匯2月15日丨泡泡瑪特(9992.HK)續升5%,3日累計反彈超12%,報42.1港元,暫成交2.97億港元,總市值590.9億港元。公司於2月11日回購36.24萬股,每股回購價介乎37.50港元至38.30港元,涉資1375.16萬港元。信達證券指出,泡泡瑪特回購彰顯長期信心,建議重點關注;大摩予泡泡瑪特“增持”評級,目標價63港元。雖然管理層未交代本輪迴購計劃金額,但認為此舉將推升市場情緒。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.